Page last updated: 2024-09-02

ecteinascidin 743 and kahalalide f

ecteinascidin 743 has been researched along with kahalalide f in 5 studies

Compound Research Comparison

Studies
(ecteinascidin 743)
Trials
(ecteinascidin 743)
Recent Studies (post-2010)
(ecteinascidin 743)
Studies
(kahalalide f)
Trials
(kahalalide f)
Recent Studies (post-2010) (kahalalide f)
66010240457518

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (80.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jimeno, JM1
Taguchi, T1
Albella, B; Bueren, JA; Faircloth, GT; Gómez, SG; Jimeno, J1
Izquierdo, MA; Jimeno, J; López-Martín, JA; Rinehart, K; Ruiz-Casado, A; Scheuer, PJ1
Vollmar, AM; von Schwarzenberg, K1

Reviews

4 review(s) available for ecteinascidin 743 and kahalalide f

ArticleYear
A clinical armamentarium of marine-derived anti-cancer compounds.
    Anti-cancer drugs, 2002, Volume: 13 Suppl 1

    Topics: Animals; Antineoplastic Agents; Depsipeptides; Dioxoles; Drug Screening Assays, Antitumor; Humans; Isoquinolines; Marine Biology; Mollusca; Peptides; Peptides, Cyclic; Tetrahydroisoquinolines; Trabectedin

2002
[Development of marine-derived anti-cancer compounds].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2003, Volume: 30, Issue:5

    Topics: Animals; Antineoplastic Agents; Clinical Trials as Topic; Depsipeptides; Dioxoles; Female; Humans; Isoquinolines; Male; Marine Biology; Mollusca; Neoplasms; Peptides; Peptides, Cyclic; Porifera; Survival Analysis; Tetrahydroisoquinolines; Trabectedin; Urochordata

2003
Progress in the clinical development of new marine-derived anticancer compounds.
    Anti-cancer drugs, 2004, Volume: 15, Issue:4

    Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Chemistry, Pharmaceutical; Clinical Trials as Topic; Depsipeptides; Dioxoles; Humans; Isoquinolines; Marine Biology; Neoplasms; Peptides; Peptides, Cyclic; Tetrahydroisoquinolines; Trabectedin

2004
Targeting apoptosis pathways by natural compounds in cancer: marine compounds as lead structures and chemical tools for cancer therapy.
    Cancer letters, 2013, May-28, Volume: 332, Issue:2

    Topics: Alkaloids; Alkanes; Animals; Anti-Bacterial Agents; Antineoplastic Agents; Apoptosis; Aquatic Organisms; Biological Products; Bryostatins; Carbamates; Cell Proliferation; Depsipeptides; Dioxoles; Drug Screening Assays, Antitumor; Humans; Lactones; Macrolides; Microtubules; Models, Chemical; Neoplasms; Phenanthrolines; Phenazines; Proteasome Endopeptidase Complex; Pyrones; Pyrroles; Quinolines; Spiro Compounds; Steroids; Tetrahydroisoquinolines; Thiazoles; Trabectedin

2013

Other Studies

1 other study(ies) available for ecteinascidin 743 and kahalalide f

ArticleYear
In vitro toxicity of three new antitumoral drugs (trabectedin, aplidin, and kahalalide F) on hematopoietic progenitors and stem cells.
    Experimental hematology, 2003, Volume: 31, Issue:11

    Topics: Animals; Antineoplastic Agents; Cell Survival; Depsipeptides; Dioxoles; Hematopoietic Stem Cells; Isoquinolines; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Peptides; Peptides, Cyclic; Tetrahydroisoquinolines; Trabectedin

2003